Delaying quality modernization may be costing more than you think. Discover the hidden costs of inaction—from recurring CAPAs and audit findings to data integrity and traceability risks. A practical session for pharma leaders assessing digital transformation and QMS sustainability.
EMEA Office
Louizalaan 489
1050 Brussels
Belgium

